oral glp 1 drugs for weight loss Patients taking an experimental GLP-1 drug lost significant and improved heart and metabolic risk factors in a large, worldwide phase 3 clinical trial led by Weill Cornell Medicine and other burn more Novo Nordisk Wins EU Approval

Tesamorelin + Ipamorelin Side Effects & Safety Compound-level safety From tesamorelin trials, the most commonly reported adverse events include injection-site reactions (redness, itching), joint pain (arthralgia), pain in the extremities, peripheral edema (fluid retention), and muscle aches

A 5mg/mL concentration allows more precise dosing at lower research dose ranges and reduces injection volume per administration

Unlike capsules, the powder format gives you flexibility

doi: 10.1186/s40168-016-0171-4 192 LupoGFDRocchettiGLuciniLLorussoLManaraEBertelliMet al

Ongoing Adjustments As you lose weight, your bodys needs change